Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Comparing the Effects of Manual Cross Friction Massage Versus Instrument-Assisted Soft Tissue Mobilization on Pain, Range of Motion, And Functional Disability in Patients With Chronic Lateral Epicondylitis: A Randomized Controlled Trial

This was a randomized controlled trial done to to compare the effect of manual Cross Friction Massage and IASTM in reducing pain , range of motion and functional disability in patients with chronic lateral epicondylitis

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

36

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • KPK
      • Peshawar, KPK, Pakistan, 25000
        • Ibadat International University, Islamabad

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Both male and female aged between 18 to 60 years with a clinical diagnosis of lateral elbow pain lasting for≥ 6 months duration VAS score ≥ 4 during resisted wrist extension or grip activity ≥1 of the following tests being positive . Mill's test pain on passive wrist flexion and elbow extension Cozen's test pain on resisted wrist extension, elbow extended, wrist in flexion and medial deviation .

Painful palpation at the origin of the ECRB or lateral epicondyle

Exclusion Criteria:

  • Participants will be excluded as:

History of recent fracture,dislocation,or surgery near the elbow joint in the last 3 month Neurological or systemic inflammatory conditions (e.g., rheumatoid arthritis) Current use of corticosteroid injections in the elbow region within the past 6 weeks Previous physiotherapy interventions for the same complaint in the last 3 months.

Skin disorders or open wounds near the treatment area.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Manual Cross Friction Massage (CFM)
Arm Description: Patient seated , elbow flexed ~90 degree , forearm pronated , extensor tendon exposed and released. Thumb / index finger applies firm transverse pressure .
Patient seated , elbow flexed ~90 degree , forearm pronated , extensor tendon exposed and released. Thumb / index finger applies firm transverse pressure . Short , deep ,rhythmic strokes perpendicular to ECRB tendon fibers (5 to 10 min ).Total duration 35 - 40 mins. 3 sessions per week for 6 weeks.
Aktiv komparator: Group B: Instrument-Assisted Soft Tissue Mobilization (IASTM)
Seated,Elbow flexed ~ 90 degree , forearm pronated, extensor tendon exposed and relaxed. Stainless steel IASTMCurve bar S shape , dual grip tool was used with moderate ,tolerable pressure .
Seated,Elbow flexed ~ 90 degree , forearm pronated, extensor tendon exposed and relaxed. Stainless steel IASTMCurve bar S shape , dual grip tool was used with moderate ,tolerable pressure . Longitudinal sweeping (1-2 min ) , Cross fiber stokes (1-2 min), Fanning over tender point ( 1- 2min). Flushing stokes (1min).40 -45 mins total time . 3 sessions per week for 6 weeks.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Visual Analog Scale.
Tidsramme: Assessments were performed at baseline (week 0) and post intervention (week 6).
A Visual Analogue Scale (VAS) was used to measure pain intensity during rest. The level of pain was recorded on a 10 cm line where 0 was classified as "no pain" and 10 was classified as "worst possible pain". Subjects were asked to indicate their pain level by placing a mark along this horizontal line
Assessments were performed at baseline (week 0) and post intervention (week 6).
Goniometer
Tidsramme: Assessments was performed at baseline (week 0) and post intervention (week 6).
ROM measured was used a standard universal goniometer, which is considered a valid, reliable, and widely accepted clinical tool for assessing joint angles in musculoskeletal conditions. Measurements were taken for wrist flexion, wrist extension, and elbow movements, following standardized positioning and landmark alignment to ensure consistency and accuracy.
Assessments was performed at baseline (week 0) and post intervention (week 6).
Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire
Tidsramme: Assessments was performed at baseline (week 0) and post intervention (week 6).
Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire The Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire is an instrument that has been developed specifically for use with this disorder [16]. It takes the form of a 15-item questionnaire, with five items addressing pain and 10 concerned with functional deficit. For each item, the respondent uses a 0- 10 numerical scale to rate the average pain or difficulty they have experienced over the previous week while carrying out various activities that are commonly painful in tennis elbow. The marking system ensures that pain and function are weighted equally in the total score. Higher scores represent greater se- verity and the maximum score is 100
Assessments was performed at baseline (week 0) and post intervention (week 6).

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

11. januar 2026

Primær fullføring (Faktiske)

28. juni 2026

Studiet fullført (Faktiske)

2. juli 2026

Datoer for studieregistrering

Først innsendt

6. juli 2026

Først innsendt som oppfylte QC-kriteriene

6. juli 2026

Først lagt ut (Faktiske)

10. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

6. juli 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • IIUI/RERC/ADT/2026/01/206

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .